跳至主要内容
临床试验/ISRCTN11853110
ISRCTN11853110已完成3 期

Randomised controlled trial of the clinical and cost effectiveness of Alpha-Stim AID cranial electrotherapy stimulation (CES) in treatment seeking patients with moderate severity depressive episodes in primary care

niversity of Nottingham0 个研究点目标入组 236 人开始时间: 2020年8月14日最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
236

研究概览

简要总结

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/35379314/ (added 05/10/2022) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/36724796/ (added 02/02/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged =16 years
  • 2. Diagnosis of current Major Depressive Episode (MDE)
  • 3. A Score of =10 or 9-item self-rated Personal Health Questionnaire (PHQ-9)
  • 4. Have either been offered the option of anti-depressant medication or prescribed antidepressant medication for a minimum of 6 weeks in the last 3 months
  • 5. Capable of giving oral and written informed consent to the study, and this consent is confirmed by the researcher at eligibility screening and baseline assessment
  • 6. Agrees to return Alpha-Stim equipment at the end of the study and not to purchase this equipment privately during the study

排除标准

  • 1. A score of =20 on the PHQ-9
  • 2) Neurological conditions e.g. brain neoplasm, cerebrovascular events, epilepsy, neurodegenerative disorders, and prior brain surgery
  • 3. Requiring urgent clinical care such as having persistent suicidal ideation, self-harm or suicidal intent.
  • 4. Known to be pregnant
  • 5. Implantation with a pacemaker or an implantable cardioverter device (ICD)
  • 6. Major unstable medical illness requiring further investigation or treatment
  • 7. A diagnosis of current substance use disorder or dependence, dementia, eating disorder, bipolar disorder or nonaffective psychosis because the use of CES treatment would otherwise require additional supervision or is associated with additional risk e.g. of mania in bipolar disorder
  • 8. Completed and benefitted from/responded to psychological treatment for depression in the last 3 months or planning to commence psychological treatment in the next 6 months
  • 9. Involved with any other clinical trial at the time of consent or 6 months prior

研究者

发起方
niversity of Nottingham

相似试验